Intra-Arterial Nimodipine for the Treatment of Symptomatic Cerebral Vasospasm after Aneurysmal Subarachnoid Hemorrhage: Preliminary Results

References

1. ↵
   Weir B, MacDonald L. Cerebral vasospasm. Clin Neurosurg 1993;40:40–55

   PubMed
2. ↵
   Paoletti C, Dematons C, Bellec C, et al. Medical management of vasospasm and hemodynamic alterations in the neurosurgical ICU. In: Connors JI, Wojak J, eds. Interventional Neuroradiology: Strategies and Practical Techniques. Philadelphia: WB Saunders Company;2000;602–612
3. ↵
   Song JK, Elliott JP, Eskridge JM. Neuroradiologic diagnosis and treatment of vasospasm. Neuroimaging Clin N Am 1997;7:819–835

   PubMed
4. ↵
   Rosenwasser RH, Armonda RA, Thomas JE, Benitez RP, Gannon PM, Harrop J Therapeutic modalities for the management of cerebral vasospasm: timing of endovascular options. Neurosurgery 1999;44:975–979; discussion 979–980

   PubMedWeb of Science
5. ↵
   Livingston K, Guterman LR, Hopkins LN. Intraarterial papaverine as an adjunct to transluminal angioplasty for vasospasm induced by subarachnoid hemorrhage. AJNR Am J Neuroradiol 1993;14:346–347

   Abstract/FREE Full Text
6. ↵
   Numaguchi Y, Zoarski GH, Clouston JE, et al. Repeat intra-arterial papaverine for recurrent cerebral vasospasm after subarachnoid haemorrhage. Neuroradiology 1997;39:751–759

   CrossRefPubMed
7. ↵
   Polin RS, Hansen CA, German P, Chadduck JB, Kassell NF. Intra-arterially administered papaverine for the treatment of symptomatic cerebral vasospasm. Neurosurgery 1998;42:1256–1264; discussion 1264–1257

   CrossRefPubMedWeb of Science
8. ↵
   Polin RS, Coenen VA, Hansen CA, et al. Efficacy of transluminal angioplasty for the management of symptomatic cerebral vasospasm following aneurysmal subarachnoid hemorrhage. J Neurosurg 2000;92:284–290

   PubMedWeb of Science
9. ↵
   Vajkoczy P, Horn P, Bauhuf C, et al. Effect of intra-arterial papaverine on regional cerebral blood flow in hemodynamically relevant cerebral vasospasm. Stroke 2001;32:498–505

   Abstract/FREE Full Text
10. ↵
    Roda JM, Carceller F, Diez-Tejedor E, Avendano C. Reduction of infarct size by intra-arterial nimodipine administered at reperfusion in a rat model of partially reversible brain focal ischemia. Stroke 1995;26:1888–1892

    Abstract/FREE Full Text
11. ↵
    Pickard JD, Walker V, Vile J, Perry S, Smythe PJ, Hunt R. Oral nimodipine reduces prostaglandin and thromboxane production by arteries chronically exposed to a periarterial haematoma and the antifibrinolytic agent tranexamic acid. J Neurol Neurosurg Psychiatry 1987;50:727–731

    Abstract/FREE Full Text
12. ↵
    Hongo K, Kobayashi S. Calcium antagonists for the treatment of vasospasm following subarachnoid hemorrhage. Neurol Res 1993;15:218–224

    PubMedWeb of Science
13. ↵
    Rasmussen G, Bergholdt B, Dalh B, Sunde N, Cold G, Voldby B. Effect of nimodipine on cerebral blood flow and cerebrovascular reactivity after subarachnoid hemorrhage. Acta Neurologica Scandinavica 1999;99:182–186

    PubMed
14. ↵
    Meyer FB. Calcium antagonists and vasospasm. Neurosurg Clin N Am 1990;1:367–376

    PubMed
15. ↵
    Pickard JD, Murray GD, Illingworth R, et al. Effect of oral nimodipine on cerebral infarction and outcome after subarachnoid haemorrhage: British aneurysm nimodipine trial. BMJ 1989;298:636–642
16. ↵
    Barker FG II, Ogilvy CS. Efficacy of prophylactic nimodipine for delayed ischemic deficit after subarachnoid hemorrhage: a metaanalysis. J Neurosurg 1996;84:405–414

    PubMedWeb of Science
17. ↵
    Feigin VL, Rinkel GJ, Algra A, Vermeulen M, van Gijn J Calcium antagonists in patients with aneurysmal subarachnoid hemorrhage: a systematic review. Neurology 1998;50:876–883

    Abstract/FREE Full Text
18. ↵
    Ohman J, Servo A, Heiskanen O. Long-term effects of nimodipine on cerebral infarcts and outcome after aneurysmal subarachnoid hemorrhage and surgery. J Neurosurg 1991;74:8–13

    PubMedWeb of Science
19. ↵
    Schmidt JF, Waldemar G. Effect of nimodipine on cerebral blood flow in human volunteers. J Cardiovasc Pharmacol 1990;16:568–571

    PubMed
20. ↵
    Feng L, Fitzsimmons BF, Young WL, et al. Intraarterially administered verapamil as adjunct therapy for cerebral vasospasm: safety and 2-year experience. AJNR Am J Neuroradiol 2002;23:1284–1290

    Abstract/FREE Full Text
21. ↵
    Bracard S, Arrue P, Barral FG, et al. Management of vasospasm from subarachnoid hemorrhage: Attitude of French centers—French Society of Neuroradiology [French]. J Neuroradiol 1999;26:S44–S47

    PubMed
22. Grotenhuis JA, Bettag W, Fiebach BJ, Dabir K. Intracarotid slow bolus injection of nimodipine during angiography for treatment of cerebral vasospasm after SAH: a preliminary report. J Neurosurg 1984;61:231–240

    PubMed
23. ↵
    Boker DK, Solymosi L, Wassmann H. Immediate postangiographic intraarterial treatment of cerebral vasospasm after subarachnoid hemorrhage with nimodipine: report on 3 cases. Neurochirurgia (Stuttg) 1985;28:118–120
24. ↵
    Fisher CM, Kistler JP, Davis JM. Relation of cerebral vasospasm to subarachnoid hemorrhage visualized by computerized tomographic scanning. Neurosurgery 1980;6:1–9

    CrossRefPubMedWeb of Science
25. ↵
    Burch CM, Wozniak MA, Sloan MA, et al. Detection of intracranial internal carotid artery and middle cerebral artery vasospasm following subarachnoid hemorrhage. J Neuroimaging 1996;6:8–15

    PubMed
26. Wozniak MA, Sloan MA, Rothman MI, et al. Detection of vasospasm by transcranial Doppler sonography: the challenges of the anterior and posterior cerebral arteries. J Neuroimaging 1996;6:87–93

    PubMed
27. ↵
    Treggiari-Venzi MM, Suter PM, Romand JA. Review of medical prevention of vasospasm after aneurysmal subarachnoid hemorrhage: a problem of neurointensive care. Neurosurgery 2001;48:249–261; discussion 261–242

    CrossRefPubMedWeb of Science
28. ↵
    Oliveira-Filho J, Ezzeddine MA, Segal AZ, et al. Fever in subarachnoid hemorrhage: relationship to vasospasm and outcome. Neurology 2001;56:1299–1304

    Abstract/FREE Full Text
29. ↵
    Schuknecht B, Fandino J, Yuksel C, Yonekawa Y, Valavanis A. Endovascular treatment of cerebral vasospasm: assessment of treatment effect by cerebral angiography and transcranial colour Doppler sonography. Neuroradiology 1999;41:453–462

    CrossRefPubMed
30. ↵
    Jennett B, Bond M. Assessment of outcome after severe brain damage. Lancet 1975;1:480–484

    PubMedWeb of Science
31. ↵
    Lindley R, Waddel F, Livingstone M, et al. Can simple questions assess outcomes after stroke? Cerebrovasc Dis 1994;4:314–324

    CrossRefWeb of Science
32. ↵
    Elliott JP, Newell DW, Lam DJ, et al. Comparison of balloon angioplasty and papaverine infusion for the treatment of vasospasm following aneurysmal subarachnoid hemorrhage. J Neurosurg 1998;88:277–284

    PubMedWeb of Science
33. ↵
    Milburn JM, Moran CJ, Cross DT III, Diringer MN, Pilgram TK, Dacey RG, Jr. Increase in diameters of vasospastic intracranial arteries by intraarterial papaverine administration. J Neurosurg 1998;88:38–42

    PubMedWeb of Science
34. ↵
    Mathis JM, Jensen ME, Dion JE. Technical considerations on intra-arterial papaverine hydrochloride for cerebral vasospasm. Neuroradiology 1997;39:90–98

    CrossRefPubMedWeb of Science
35. ↵
    Clouston JE, Numaguchi Y, Zoarski GH, Aldrich EF, Simard JM, Zitnay KM. Intraarterial papaverine infusion for cerebral vasospasm after subarachnoid hemorrhage. AJNR Am J Neuroradiol 1995;16:27–38

    Abstract
36. ↵
    Arakawa Y, Kikuta K, Hojo M, Goto Y, Ishii A, Yamagata S. Milrinone for the treatment of cerebral vasospasm after subarachnoid hemorrhage: report of seven cases. Neurosurgery 2001;48:723–728; discussion 728–730

    CrossRefPubMedWeb of Science
37. ↵
    Chow M, Dumont AS, Kassell NF. Endothelin receptor antagonists and cerebral vasospasm: an update. Neurosurgery 2002;51:1333–1342

    CrossRefPubMedWeb of Science
38. ↵
    Clark J, Pyne G, Choutka O, et al. In vitro therapy with dobutamine, isoprenaline and sodium nitroprusside protects vascular smooth muscle metabolism from subarachnoid hemorrhage induced cerebral vasospasm. Acta Neurochir (Wien) 2001;143:721–728

    PubMed
39. ↵
    Takayasu M, Bassett JE, Dacey RG, Jr. Effects of calcium antagonists on intracerebral penetrating arterioles in rats. J Neurosurg 1988;69:104–109

    PubMedWeb of Science
40. ↵
    Zygmunt SC, Delgado-Zygmunt TJ. The haemodynamic effect of transcranial Doppler-guided high-dose nimodipine treatment in established vasospasm after subarachnoid hemorrhage. Acta Neurochir (Wien) 1995;135:179–185

    PubMed
41. ↵
    Yakes WF, Krauth L, Ecklund J, et al. Ethanol endovascular management of brain arteriovenous malformations: initial results. Neurosurgery 1997;40:1145–1152; discussion 1152–1144

    PubMed